The confusion may be caused by the decreasing DKK3 expression with increasing tumor grade, resulting in DKK3 appearing to be a tumor suppressor gene; however, in GBM, it acts as an oncogene because increased expression of the gene is associated with poor patient prognosis. This evidence concerns the gene DKK3 and glioblastoma.